Studies have shown that, unless hamsters were primed by prior infection with an influenza A virus, the animals would not produce serum hemagglutination inhibition (HI) (11) . Before testing, sera were treated with cholera filtrate (Burroughs Wellcome Ltd.) for 18 h at 37 C and subsequently heated for 1 h at 56 C. Serum dilutions were incubated for 10 to 15 min with eight hemagglutinating units of virus (50% end-point) before adding fowl erythrocytes. The HI titers were read after the cells had settled at room temperature and were expressed as the highest serum dilution which caused a 50% reduction in virus hemagglutination.
Experimental design. All the studies were carried out in 2-to 3-month-old Syrian hamsters from a single closed, randomly bred colony at the University of Sheffield. Prior to tests, a blood sample (0.5-1.0 ml) was collected from the orbital sinus of each hamster using a finely drawn Pasteur pipette. Groups of hamsters were then infected intranasally and under light ether anesthesia with 0.2 ml of a live influenza virus preparation; the dose of virus used had been shown in preliminary studies to induce serum HI antibody, and contained 105-5 to 10865 mean egg infective dose (EID,0)/ml. Three weeks after virus infection a further blood sample was obtained from each hamster, and the animals were immunized by intramuscular injection of inactivated virus vaccine or split virus vaccine in an 0.5-ml volume. A third blood specimen was collected 3 weeks after immunization. All hamster sera were stored at -20 C.
Rate-zonal centrifugation. Hamster sera were treated with cholera filtrate for 18 h at 37 C, and then heated at 56 C for 1 h. Linear sucrose gradients of approximately 5.0-ml volume were prepared with the aid of a mixing device from 5 and 20% (wt/vol) sucrose (Analar) in phosphate-buffered saline (pH 7.4), and kept for 1 h at 4 C. The sucrose gradients were layered with 0.2 ml of treated hamster serum mixed with 0.02 ml of human serum; the human serum was included to provide immunoglobulin yM and yG markers of known sedimentation coefficients. After centrifugation at 100,000 x g for 5 h in a Spinco L preparative centrifuge at 4 C, and using an SW50 swinging-bucket rotor, 14-drop volumes were collected from the gradients through a needle inserted into the base of the centrifuge tubes. Each fraction was titrated for HI antibody and for human immunoglobulins yG and yM.
The human serum used to supply immunoglobulin markers for the rate-zonal centrifugation studies was obtained from a patient with Waldenstrom macroglobulinemia. The serum contained low levels of HI antibody to influenza viruses, and these were removed by absorption. Samples (10 ml) of influenza viruses A2/Hong Kong/1/68, A1/FM/1/47, and A/PR/8/34 were centrifuged at 100,000 x g for 40 min, and the pellets were resuspended in 2.0 ml of the human serum sample. After overnight incubation at 4 C, the sample was centrifuged at 100,000 x g for 40 min and the pelleted material was discarded. This procedure removed detectable HI antibody to the viruses used for absorbtion. The sample was further incubated for 4 h at 4 C with packed fowl cells (final concentration 10%) to remove fowl red cell agglutinins. The serum contained 550 mg of yG per 100 ml and 1,700 mg of -yM per 100 ml; these levels were sufficiently high that 0.02 ml of the serum added to the layered hamster serum sample gave easily detectable peaks of both immunoglobulins in the fractions collected after centrifugation. The concentration of -yM and yG in the samples from the sucrose gradients was determined by single radial immunodiffusion (2) with the specific antisera prepared against the human immunoglobulins (Burroughs Wellcome Ltd.).
Adoptive transfer of serum or lymphocytes. Twenty-one days after intranasal infection of hamsters with influenza virus A2/Hong Kong/1/68 or A1/FM/1/47, the animals were killed, and the blood, spleens, and thymuses were removed. The organs were finely minced, and the tissue was suspended in medium 199 and further broken down by extrusion of the fragments through a syringe without a needle. The suspension was then filtered through sterile cotton gauze to remove the remaining tissue fragments. The resulting cell suspension, almost entirely composed of single cells, was centrifuged at 1,000 x g for 10 min, and distilled water was added to the deposited cells for 30 s (3 ml of water per 0.1 ml of sedimented cells) to lyse the red blood cells; the medium was restored to isotonic strength by adding an equal volume of doublestrength saline. The cells were washed three times in medium 199 and resuspended in the same medium to a concentration of 5 x 106 viable cells/ml and used immediately to inoculate hamsters.
Normal, adult hamsters were each given 100 rads of X irradiation; this treatment reduced the hamster peripheral leukocyte count by 10 to 30%, but the count returned to normal values 7 to 10 days after treatment. Twenty-four hours after irradiation, groups of hamsters were inoculated intraperitoneally with 5 x 106 spleen cells or thymus cells. Further groups of hamsters were inoculated by the intraperitoneal route with 0.5 ml of serum collected from hamsters 21 days after influenza virus infection. The following day, a blood sample was collected from each hamster, and the animals were then immunized intramuscularly with influenza virus vaccine. A further blood sample was collected 3 weeks after immunization.
RESULTS
Immunization of hamsters with A2/Aichi/ 2/68 vaccine following infection with influenza virus Al/FM/l/47. Hamsters were infected intranasally with influenza virus Al/ FM/1/47; serum specimens collected 3 weeks after infection showed that all the animals had developed serum HI antibody to the infecting INFECT. IMMUNITVY virus. The hamsters were then divided into groups of three or four and immunized with different concentrations of inactivated influenza virus A2/Aichi/2/68 vaccine. Similar extinction titrations of the vaccine were carried out in normal hamsters. Blood specimens were collected 3 weeks after immunization, and the results of HI antibody tests on these sera are shown in Table 1 .
Immunization of normal hamsters with 1,500 CCA of influenza A2/Aichi/2/68 virus vaccine produced serum HI antibody to A2/Hong Kong/68 virus in all four animals at titers of 1: 15 to 1: 60; however, inoculation with doses of 500 CCA or less of vaccine failed to induce detectable levels of HI antibody (Table 1 ). In contrast, for hamsters which had been previously infected with influenza virus A1/FM/1/47, immunization with 15 CCA of A2/Aichi/2/68 vaccine produced serum HI antibody at titers of 1: 15 to 1: 40, but inoculation with 1.5 CCA with 150 CCA of inactivated A1/FM/1/47 vaccine. This was probably due to the passively acquired antibody which prevented the HI antibody response to the vaccine and which had disappeared by 21 days after immunization (Table 3) ; similar results have been reported for rabies vaccine (13) .
Rate-zonal centrifugation studies of hamster HI antibody. Groups of hamsters were infected intranasally and under ether anesthesia with influenza virus A1/FM/1/47, A/ PR/8/34, or A2/Hong Kong/1/68; blood samples were collected 8 days and 21 days after infection. At this time, the hamsters were inoculated with 150 CCA of inactivated influenza virus A2/Aichi/2/68 vaccine, and further blood samples were taken 8 and 21 days after immunization. The serum specimens were tested for HI antibody and were examined by rate-zonal centrifugation in 5 to 20% linear sucrose gradients to determine the sedimentation coefficients of the antibody. Figure 1 shows the sedimentation pattern of the HI antibody present in the serum 8 days and 21 days after infection with influenza virus A1/FM/1/47. For the serum specimen taken 8 days after infection, the HI antibody was detected in two peaks; the position of one peak coincided with that of human -yM, and the second peak corresponded to human yG (Fig.  1A) . The serum HI antibody present at 21 days after virus infection was detected only in a single peak which was coincidental with that of human 7yG, included in the gradient as a marker (Fig. 1B) . This same hamster, previously infected with influenza virus A1/FM/1/47, was immunized with 150 CCA of inactivated A2/ Aichi/2/68 vaccine, and serum specimens were collected 8 and 21 days later. These specimens were also studied by rate-zonal centrifugation in linear sucrose gradients, and the results showed that at both times all the detectable HI antibody was present in a single peak corresponding to that of human yG (Fig. 1C and D) . Thus, the initial infection gave an antibody response typical of a primary infection, producing both 19S and 7S HI antibody, while the subsequent response to immunization was typical of a secondary response with only 7S HI antibody detected.
Results similar to those shown in Fig. 1 . The mechanism for the increased responsiveness of primed animals to influenza virus vaccines is not known. However, it is suggested that the exaggerated response to the new virus hemagglutinin was due to the virus hemagglutinin being complexed with carrier antigen of either the whole virus particle or to a portion of the virus hemagglutinin to which the hamster has already responded; thus, the infecting virus and the vaccine virus both contain ribonuclear protein and matrix antigens which are common to all influenza A viruses (9) . The suggested mechanism underlying the increased responsiveness of primed hamsters to inactivated influenza virus vaccines is the same as that proposed to account for observations of other antigen-carrier or hapten-carrier systems. Thus, rabbits or guinea pigs previously immunized with bovine yG show a markedly augmented response to subsequent inoculation of 2, 4-dinitrophenol when coupled with bovine yG (1) . Similar results have been reported by other workers using other carrier systems (3, 7, 8, 10, 12) . From these studies, a number of features of the proposed mechanism have been shown. Thus, the new antigenic determinant must be coupled to the carrier virus particle (8, 12) , and secondly the mechanism for the exaggerated response is based on observations which show that the antibody response to immunization of primed animals is a secondary response (8) . These two features were tested in the present study.
In the present study, hamsters some portion of the virus may remain intact or some reaggregation may take place after etherTween treatment. The response of primed hamsters to purified, heterotypic hemagglutinins is now being studied. Rate-zonal centrifugation studies in linear sucrose gradients showed that the antibody response to inactivated influenza virus A2/Aichi/2/68 vaccine in serum collected 8 days after inoculation of primed hamsters was entirely 7S. The result was strongly suggestive of a secondary response, since sera collected eight days after primary virus infection contained either 19S or 7S and 19S antibody.
Adoptive transfer experiments showed that inoculation of normal hamsters with lymphocytes from hamsters previously infected with influenza virus A1/FM/1/47 transferred the property of increased responsiveness to A2/ Aichi/2/68 vaccine; similar results were obtained for guinea pigs inoculated with haptenbovine -y-globulin complex following inoculation of lymphoid cells from animals immunized with bovine y-globulin (6) . Passive immunization with serum from primed hamsters did not potentiate the later response to virus vaccine; thus, the presence of humoral antibody to the carrier virus particle was not sufficient to prime animals. The suggested mechanism of the priming effect requires the mutual cooperation of lymphocytes in the response (8, 12) ; our results further indicate the importance of lymphocytes in the mechanism of primed response.
Although normal hamsters and ferrets do not produce serum HI antibody in response to inoculation with 300 CCA of inactivated influenza virus A2/Aichi/2-68 vaccine, this dose produces a good antibody response in volunteers (4, 5) . It remains possible that the response in man is due to prior infection by homotypic or heterotypic influenza A virus and that the response to vaccine is dependent to some degree on a priming infection.
